Technology Showcase:
Advanced Analytical Strategies for NextGen Antibodies

17 September 2026 | Online, BST (UTC+1)

SPONSORED BY

Oxford Global Logo Standard

Uncover the latest in cell line development, where CRISPR, AI, and automation are driving faster, more precise engineering

Antibodies are versatile but must meet key attributes for scalable, safe therapeutics. While standard developability assays guide mAb design, next-generation formats demand smarter, more targeted characterisation. This session will also showcase high-throughput ADC characterisation, focusing on free drug levels to accelerate development.

  • Gain Cutting-Edge Insights – Learn the latest analytical approaches to characterise standard and next-generation antibodies.
  • Accelerate Development Decisions – Discover how high-throughput and targeted assays can guide developability and optimise therapeutic design.
  • Engage with Experts – Connect with leading scientists and thought leaders driving innovation in antibody characterisation.

This is your chance to see the latest tools in action, understand their real-world impact, and leave with practical takeaways to apply in your own research.

VPs, Directors & Senior Managers from leading pharma & biotech companies and research institutions in the following fields and more:

 

  • Analytical Development
  • Quality Control
  • CQA
  • Antibody Characterisation
  • Developability Assessment
  • Assay Development 

60-Minute Agenda

14:00 - 14:15

Industry Presentation: New Frontiers In Rationalising Mabs Developability Testing

Presentation Recording
DAVID BROCKWELL
Professor, University of Leeds
14:15 – 14:30

Industry Presentation: Revolutionising ADC Characterisation With High Throughput Techniques

Presentation Recording
SARAH HINDSON
Scientific Investigator, GSK
14:30 – 14:45

Solution Provider Presentation

For sponsorship opportunities please contact: sponsorship@oxfordglobal.com
14:45 – 15:00

See The Technology In Action + Live Q&A

Speakers and Solution Provider Panel Discussion
15:00

End of Technology Showcase

Agenda

13:40 – 14:00

Industry Presentation: TACAs: Opening up the Target Space to a New Frontier

PETER SONDERMANN
Chief Executive Officer, Tacalyx
14:00 – 14:20

Industry Presentation: Innovative Strategies For Efficient NK Cell Redirection

LUKAS PEKAR
Lab Head, Merck KGaA
14:20 – 14:40

Solution Provider Presentation

For sponsorship opportunities please contact: sponsorship@oxfordglobal.com
14:40 – 15:00

See The Technology In Action + Live Q&A

15:00

End of Technology Showcase

About Technology Showcases

Our Technology Showcases are interactive, online events that bring together leading experts and innovators to share insights on the latest technology in a specific field.

This series is designed for industry professionals, scientists and researchers to stay ahead of the latest innovations. Each showcase spotlights a critical real-world success story, where leading experts share how cutting-edge technologies are transforming research and overcoming key challenges.

Each showcase features two expert talks from leaders in the field, followed by an in-depth exploration and demonstration of new technologies from our Solution Providers and a live Q&A. Gain practical insights and witness technologies in action.